Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.
Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...
Liraglutide, a generic of Saxenda, is approved to treat adults and adolescents who are obese or overweight. If approved, ...
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so ...
Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...
Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on Thursday, May 8, 2025. (AP Photo/JoNel Aleccia) People taking Eli Lilly's obesity drug, Zepbound, lost ...
Eli Lilly reports Phase 3 data showing oral obesity drug orforglipron maintained weight loss after Wegovy or Zepbound, beating placebo.
Baylen Out Loud' star Baylen Dupree is feeling body confident as she says goodbye to 2025 and shares her experience with a ...
Nausea is the most common tirzepatide side effect. In Zepbound clinical trials, 25 to 28 percent of people reported nausea.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback